LGM
VERA icon

Logos Global Management’s Vera Therapeutics VERA Stock Holding History

Logos Global Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.4M Buy
+2,200,000
New +$82M 4.06% 6
2025
Q1 		– Sell
-875,000
Closed -$37M – 56
2024
Q4 		$37M Buy
875,000
+375,000
+75% +$16.6M 4.33% 5
2024
Q3 		$22.1M Sell
500,000
-450,000
-47% -$17.1M 2.38% 18
2024
Q2 		$34.4M Buy
950,000
+375,000
+65% +$14.9M 2.76% 12
2024
Q1 		$24.8M Buy
+575,000
New +$20.5M 2.01% 17
2023
Q1 		– Sell
-285,000
Closed -$5.51M – 48
2022
Q4 		$5.51M Buy
+285,000
New +$5.16M 0.65% 32
2022
Q2 		– Sell
-385,000
Closed -$9.04M – 41
2022
Q1 		$9.04M Buy
385,000
+335,000
+670% +$7.21M 1.17% 23
2021
Q4 		$1.34M Buy
+50,000
New +$1.11M 0.14% 59

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Logos Global Management's VERA Position: Q2 2026 in Review

Logos Global Management opened a new position in Vera Therapeutics (VERA) in Q2 2026: 2,200,000 shares worth $94.4M. The stake represents 4.06% of the portfolio and ranks #6 among its holdings. This is a return to the name: Logos Global Management previously reported a position in VERA as recently as Q4 2024.

Logos Global Management first reported a position in VERA in Q4 2021 and has held it in 8 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Logos Global Management held 2,200,000 shares of Vera Therapeutics worth $94.4M as of Q2 2026.
  • Vera Therapeutics was a new Logos Global Management position in Q2 2026.
  • Vera Therapeutics made up 4.06% of Logos Global Management's portfolio in Q2 2026, its #6 holding.
  • Logos Global Management first reported a position in Vera Therapeutics in Q4 2021 and has held it in 8 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Logos Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.